Novo Nordisk Partners With OpenAI To Accelerate Drug Discovery
The company said Artificial Intelligence will be used to analyse complex datasets, identify potential drug candidates and reduce the time taken to move from research to clinical application.
Hosted on MSN
Wegovy maker Novo Nordisk strikes deal with OpenAI to speed up drug discovery
Novo Nordisk said it would work with ChatGPT maker OpenAI on how to leverage artificial intelligence to discover new drugs, the latest AI partnership in the medical field as healthcare companies seek ...
Hosted on MSN
Novo Nordisk partners with OpenAI as AI drug discovery hopes mount
Novo Nordisk is partnering with OpenAI to "bring new and better treatment options to patients faster," the Danish drugmaker said Tuesday. "Integrating AI in our everyday work gives us the ability to ...
Tech Times
GPT-Rosalind Drug Discovery Update: OpenAI Cuts Genomics Compute, Expands Global Access
GPT-Rosalind drug discovery capabilities updated June 3 with three new benchmarks showing the domain-specialized model cuts ...
Insider Monkey
Novo Nordisk Announces Partnership with OpenAI
Novo Nordisk A/S (NYSE:NVO) is included among the 10 Best Affordable Blue Chip Stocks to Buy Now. Novo Nordisk A/S (NYSE:NVO) is a leading global healthcare company, founded in 1923 and headquartered ...
The Motley Fool
Is This Deal a Game Changer for Novo Nordisk?
On April 14, Novo Nordisk announced that it had entered into a partnership with OpenAI. The two companies will collaborate to bring cutting-edge artificial intelligence (AI) capabilities to the drug ...